← brief for 2026-10-13 · Slowing decline

Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional capacity in heart failure: a systematic review and meta-analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This large review combined data from several studies on the drug tirzepatide. It looked at how the drug affects heart and kidney markers in people with heart failure. It found that the drug improved these markers compared to placebo. This suggests the drug may help protect the kidneys in these patients.

Who did this work

Eisa N · Khoury M

Source

Article · PubMed, the drug frontier · 2026 Oct 13
https://pubmed.ncbi.nlm.nih.gov/42867450/